2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $6.7B | $7.9B | $8.5B | $8.4B | $7.7B |
Cost of Revenue | $4.2B | $4.9B | $5.4B | $5.4B | $4.8B |
Gross Profit | $2.5B | $3B | $3.1B | $3.1B | $3B |
Gross Profit % | 37% | 38% | 36% | 37% | 38% |
R&D Expenses | $142M | $158M | $163M | $153M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $683M | $1.1B | $1.1B | $1.1B | $2.7B |
Dep. & Amort. | $279M | $290M | $308M | $317M | $338M |
Def. Tax | -$26M | -$48M | -$28M | -$99M | $0 |
Stock Comp. | $25M | $31M | $31M | $31M | $40M |
Chg. in WC | $142M | -$108M | -$585M | $50M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $513M | $386M | $381M | $399M | $1.8B |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $513M | $386M | $381M | $399M | $1.8B |
Receivables | $1.1B | $1.3B | $1.5B | $1.4B | $1.4B |
Inventory | $836M | $1.2B | $1.4B | $1.2B | $1.1B |
Q1 adjusted EPS increased 19% year-over-year, with record adjusted EBITDA margin of 24% (up 240 bps), driven by strong incremental margin conversion, cost actions, and positive price/cost dynamics; four out of five segments posted over 100 bps of margin expansion.
Bookings were up for the sixth consecutive quarter, with a book-to-bill ratio above one across all segments, resulting in a sizable Q2 revenue backlog; management remains encouraged by order rates and backlog visibility for Q2.
Revenue and EPS guidance for the full year was modestly trimmed to reflect uncertainty in the demand environment for the second half of the year due to ongoing tariff negotiations; guidance for 2025 free cash flow remains on track at 14%-16% of revenue.
Tariff exposure, particularly on Chinese imports (notably structural steel in Vehicle Services), is being addressed primarily through pricing actions; management expects to offset most tariff costs with price, but is cautious about potential volume impact in the second half.
Clean Energy & Fueling and Pumps & Process Solutions segments showed strong organic growth and margin improvement; management expects Clean Energy & Fueling to lead margin accretion in 2025, and sees continued robust growth in biopharma components, thermal connectors, and CO2 refrigeration systems.